Business Context and Reporting Period
This Form 8-K was filed by Flora Growth Corp. (NASDAQ: FLGC), not Zerostack Corp., and reports an event dated September 17, 2023. Flora entered into a Sale and Purchase Agreement with Lifeist Wellness Inc. to acquire Australian Vaporizers Pty Ltd. (“AV”), an Australian online retailer of vaporizers, hardware, and accessories.
Transaction and Key Financial Terms
- Flora agreed to acquire 100% of AV’s issued and outstanding common shares.
- Consideration consists of up to 600,676 Flora common shares issued to Lifeist.
- The shares were valued at approximately $1.7 million based on Flora’s closing share price on September 15, 2023.
- The consideration is subject to reduction based on AV’s cash, inventory and inventory deposits, and working capital at closing.
- The proposed share issuance is intended to rely on the exemptions under Section 4(a)(2) and/or Rule 506 of Regulation D.
- The filing does not provide AV revenue, earnings, cash flow, margins, debt, or liquidity figures.
Material Changes and Transaction Status
The transaction was pending and had not closed as of the filing. Closing was anticipated during Flora’s fourth quarter of fiscal 2023, but the company stated that completion was not assured.
Required conditions include non-competition agreements from Lifeist, an employment agreement with a key AV employee, accuracy of specified representations and warranties, material compliance with transaction covenants, and the absence of a material adverse effect on AV.
Outlook, Risks, and Unusual Items
- Management identified potential benefits from acquiring AV but did not quantify expected revenue, earnings, or other financial impacts.
- Key risks include failure to satisfy closing conditions, delays or failure to close, and difficulties integrating AV.
- The transaction would result in potential equity dilution of up to 600,676 Flora shares, subject to the purchase-price adjustment.
- Forward-looking statements are subject to risks described in Flora’s Form 10-K and other SEC filings. Flora undertook no obligation to update those statements.
- A press release announcing the agreement was issued on September 18, 2023.
Important Facts for Investors to Verify
- Verify the filing issuer: the provided filing is for Flora Growth Corp., whereas the request metadata identifies Zerostack Corp.
- Review the complete Purchase Agreement and any subsequent filing confirming whether the transaction closed.
- Confirm the final number and value of Flora shares issued after the cash, inventory, deposits, and working-capital adjustment.
- Assess AV’s historical financial performance, assets, liabilities, and liquidity, which are not provided in this filing.
- Review subsequent disclosures for integration costs, dilution, acquisition accounting, and changes to Flora’s outlook.